Quick Answer
Quoin Pharmaceuticals, Ltd. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2021.
Quoin Pharmaceuticals, Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2021 | -$0.01 | +98.6% |
| 2020 | -$0.70 | -34.6% |
| 2019 | -$0.52 | — |
- Quoin Pharmaceuticals, Ltd. showed an increase of +98.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2021 period, Quoin Pharmaceuticals, Ltd.’s diluted eps has grown by 98.1% (from $0.52 per share (loss) to $0.01 per share (loss)).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2021 report (Form 20-F), filed with the SEC on April 14, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: